Moberg Pharma reports new Phase 3 analyses on terbinafine activity in onychomycosis

GE HealthCare to acquire SOFIE Biosciences for USD945m

Ractigen Therapeutics reports positive first-in-human data for RAG-18 in Duchenne muscular dystrophy

CSL and Alentis partner for lixudebart development and commercialisation for rare kidney and liver diseases

AnnJi Pharmaceutical's AJ201 advances into pivotal Phase 3 trial for SBMA

Teva reports new ecopipam data showing tic reduction in Tourette syndrome

Johnson & Johnson reports two-year ICOTYDE data showing sustained clearance in high-impact psoriasis

Clear Scientific reports positive CS-1103 Phase 2 Results in removing fentanyl from the Body

Avimer Bio and CNIO publish JACS study on computational design of self‑assembling protein cages

MHRA approves Zepzelca and atezolizumab as first-line maintenance therapy for ES-SCLC in the UK

Pfizer's tilrekimig shows significant skin clearance in Phase 2 atopic dermatitis study

Sanofi and Regeneron expand antibody alliance with four next-generation immunology programmes

AFYREN ingredient enables global launch of natural propionic acid skincare product

Fresenius acquires remaining stake in mAbxience

Lilly reports positive 48-week Phase 2b resu;ts for EloraTZP